Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Optimising the vaccine strateg...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Export Ready — 
Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control

Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control

Bibliographic Details
Main Authors: Wajja, A, Nassanga, B, Natukunda, A, Serubanja, J, Tumusiime, J, Akurut, H, Oduru, G, Nassuuna, J, Kabagenyi, J, Morrison, H, Scott, H, Powell Doherty, R, Marshall, JL, Cabrera Puig, I, Cose, S, Kaleebu, P, Webb, EL, Satti, I, McShane, H, Elliott, AM
Other Authors: TB042 Study Team
Format: Journal article
Language:English
Published: Elsevier 2024
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial
    by: Wajja, A, et al.
    Published: (2023)
  • The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial
    by: Wajja, A, et al.
    Published: (2017)
  • The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.
    by: Anne Wajja, et al.
    Published: (2017-05-01)
  • Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A
    by: Wajja, A, et al.
    Published: (2018)
  • DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
    by: Mcshane, H
    Published: (2008)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs